| Name | Title | Contact Details |
|---|
JRC Assisted Living Inc is a Peabody, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
MDR LLC. is a New York, NY-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
An innovative healthcare platform offering quick and simple access to a vast portfolio of mental health providers. Through the mobile app available on both iOS and Android, individuals can access professionals covering over 25 categories of support at low costs with discounted student and standard rates. At zant, we are dedicated to creating a world where mental health services are accessible, affordable, and available to all.
Animal Dermatology Group is a veterinary dermatology specialty company with the worlds largest unified group of veterinary dermatology specialists engaged in the diagnosis and treatment of acute and chronic skin conditions in pets.
Assembly Biosciences (NASDAQ: ASMB) is a clinical-stage biotechnology company developing innovative therapeutics targeting hepatitis B virus (HBV) and diseases associated with the microbiome. The HBV program is focused on advancing a new class of potent, oral core inhibitors that have the potential to increase cure rates for chronically infected patients. The microbiome program is developing novel oral live microbial biotherapeutic candidates with Assembly`s fully integrated platform, including a robust process for strain identification and selection, GMP banking and production, and targeted delivery to the lower gastrointestinal tract with the GEMICEL® technology. We pride ourselves on creating a culture and work environment that is scientifically driven, ambitious, and collaborative. We encourage diversity of thought that leads to great innovation and are looking to add to our dynamic team great people who are driven to transform the lives of patients. We believe our Microbiome platform represents a best in class approach to developing biopharmaceutical agents from live biotherapeutic products. ABI-M201, our lead program in mildly to moderately active ulcerative colitis (UC), is currently in a phase 1b clinical trial. This program is part of a broader collaboration we established with Allergan in 2017 for gastrointestinal programs such as UC, Crohn`s disease and Irritable Bowel Syndromes with potential total development and commercial milestones of up to $2.8 billion. Our internal pipeline comprises first in class or best in class live microbial biotherapeutic approaches in areas such as oncology, immune mediated and metabolic disorders, and other areas of high medical need. Assembly is headquartered in Carmel, Indiana, while the R&D headquarters is in South San Francisco. The Company also has a microbiome manufacturing facility in Groton, CT, and offices in China.